Solian is a medicine used to treat mental health conditions like schizophrenia. It helps manage symptoms like hallucinations and delusions. It's taken as a pill, usually once a day.
Every report comes from a Lived member, sent anonymously.
Have you tried Solian (Amisulpride) for Schizophrenia?
Amisulpride, sold as Solian in Ireland and other countries and as generic tablets in the UK and elsewhere, is an antipsychotic medicine used to treat schizophrenia. It is prescribed both for an acute episode and as longer-term treatment. It can help with positive symptoms, such as hallucinations, delusions and disordered thinking, and with negative symptoms, such as flattened emotions, low motivation and social withdrawal. At low doses it has also been studied for dysthymia, a long-lasting form of low mood, but that is not a licensed use in the UK or Ireland. Oral amisulpride is not approved in the United States, and Solian is not sold there. In the US, amisulpride is available only as Barhemsys, an injection given into a vein by the anesthesia team to prevent or treat nausea and vomiting after surgery in adults. Barhemsys is a single hospital dose, not a daily medicine, and it is not approved for oral or long-term use.
Dopamine is a chemical messenger that carries signals between nerve cells. In schizophrenia, overactive dopamine signaling in certain brain pathways is thought to contribute to symptoms such as hallucinations and delusions. Amisulpride blocks two types of dopamine receptors, called D2 and D3, which dampens that signaling. Unlike many other antipsychotics, it has almost no effect on serotonin, histamine or adrenaline receptors, which helps explain why it tends to cause less sedation and weight gain than some alternatives but more hormone-related side effects. Dose changes how it acts. At low doses it mainly blocks receptors that normally limit dopamine release, which may increase dopamine activity in some areas and is thought to explain its effect on negative symptoms. At higher doses it blocks dopamine signaling more broadly, which treats positive symptoms. Blocking dopamine in the brain's vomiting trigger zone is also why a single small injection works against nausea after surgery.
Oral amisulpride comes as tablets and, in some countries, a liquid. It can be taken with or without food. The dose depends on which symptoms are being treated: lower doses are used when negative symptoms predominate, and higher doses for an acute psychotic episode. Lower daily doses are usually taken once a day, while higher doses are split into two. The prescriber adjusts the dose to response and then aims for the lowest dose that keeps symptoms controlled. Amisulpride is cleared almost entirely by the kidneys, so people with reduced kidney function need a lower dose, and it is not used when kidney function is severely reduced. Stopping suddenly can cause withdrawal symptoms such as nausea, vomiting and trouble sleeping, new movement problems, and a return of psychotic symptoms, so any stop should be planned with the prescriber and done gradually. Barhemsys is given only by a clinician as a single intravenous dose, either at the start of anesthesia to prevent nausea or after surgery if nausea or vomiting develops.
Movement-related effects are among the most common with oral amisulpride, particularly at higher doses: tremor, stiffness, slowed movement, drooling and akathisia (an uncomfortable inner restlessness and urge to keep moving). Sudden muscle spasms of the neck, jaw or eyes can occur early in treatment. These effects often ease with a dose change or added medicine, so they are worth reporting rather than enduring. Long-term use can rarely cause tardive dyskinesia, repetitive involuntary movements of the face and tongue that may persist. Amisulpride commonly raises prolactin, a hormone that controls breast milk production. This can cause breast milk leakage, missed or irregular periods, breast enlargement or tenderness (in men as well as women) and erectile or orgasm problems. These changes usually reverse after stopping. Rarely, high prolactin is linked to a benign pituitary tumor; persistent headaches or changes in side vision should be reported. Other common effects include insomnia, anxiety, sleepiness, constipation, nausea, dry mouth, blurred vision, dizziness from low blood pressure and weight gain. Rare but serious reactions include neuroleptic malignant syndrome, a reaction to antipsychotics that causes high fever, stiff muscles, confusion, sweating and a fast heartbeat, and dangerous heart rhythm problems. Fever with stiff muscles or confusion, fainting, or a racing or irregular heartbeat needs emergency care. Contact the prescriber right away about yellowing of the skin or eyes with unusual tiredness, nausea or abdominal pain. The same applies to unexplained fever or repeated infections, a possible sign of a low white blood cell count. After a Barhemsys injection, side effects are usually mild and short-lived, such as pain at the injection site, chills, low blood pressure, low potassium or a brief rise in prolactin.
Amisulpride can lengthen the QT interval, the part of the heartbeat measured on an electrocardiogram (ECG) that reflects how the heart resets between beats. A longer QT raises the risk of a rare but dangerous rhythm problem. The risk is higher with a slow heart rate, heart disease, a personal or family history of sudden death or long QT, and low potassium or magnesium (for example from diuretics, vomiting or diarrhea). An ECG is recommended before starting oral treatment, and blood salts may be checked during treatment. The same concern makes several combinations risky or off limits. These include certain antidepressants such as citalopram and escitalopram, other antipsychotics, methadone (an opioid used for pain and addiction treatment), heart rhythm medicines such as amiodarone and sotalol, some antibiotics and antifungals (the pharmacist should check any new one), and antinausea medicines such as ondansetron and droperidol. Amisulpride and levodopa or other dopamine-boosting Parkinson's medicines work against each other, so they are generally not combined, and amisulpride can worsen Parkinson's disease. Alcohol, sleeping pills, opioids and other sedating medicines add to drowsiness, which can make driving unsafe. The prescriber and pharmacist should see a full list of medicines and supplements. Amisulpride is not used in children under 15 and is not recommended from 15 to 18. It is also not used in people with a prolactin-dependent tumor such as some breast cancers or a prolactinoma, or with pheochromocytoma (an adrenaline-producing tumor). Amisulpride is generally not recommended for people over 65: safety data are limited, low blood pressure and sedation are more likely, and declining kidney function can require dose changes. Separately, antipsychotics increase the risk of stroke and death in older people with dementia. Other conditions that call for closer monitoring include epilepsy, diabetes, a history of blood clots and a family history of breast cancer. Amisulpride passes into breast milk in large amounts, and its safety in pregnancy is not established. Babies exposed late in pregnancy can have temporary movement or withdrawal symptoms after birth. Anyone pregnant, planning pregnancy or breastfeeding should discuss the balance of risks with the prescriber rather than stopping on their own, since untreated schizophrenia also carries risks.
Some effects, such as calmer agitation or better sleep, can appear in the first days or weeks, while fuller improvement in hallucinations, delusions or motivation usually builds over several weeks. Side effects can show up before benefits. In comparisons with other newer antipsychotics, amisulpride appears roughly as effective as olanzapine and risperidone and tends to cause less weight gain, although the trials were short and few, so individual response matters more than averages. Follow-up usually includes checking how symptoms are responding and watching for movement effects, hormone-related changes, weight, blood sugar and cholesterol, with ECGs or blood tests when risk factors or dose increases call for them. Because schizophrenia often relapses when treatment stops, many people continue an antipsychotic long term once it works, at the lowest effective dose. If amisulpride is not effective or not tolerated, switching to another antipsychotic is common, and medication typically works best alongside psychological support and help with daily life.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Solian (Amisulpride), what you've noticed, or ask the community a question.